This course provides an overview of GLP regulations as they are applied and interpreted by the FDA, EPA and the Organization for Economic Cooperation and Development. Good Laboratory Practices (GLPs) ...

Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...

New data shows widespread undetected metabolic risk – even among “healthy” individuals – as Noom enables members to test, treat, and track progress from home Simple, at-home blood collection delivers ...

For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 receptor agonists like semaglutide and tirzepatide. Now, a phase 2 clinical ...

Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into ...

AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today ...

Samsung has teamed up with diabetes experts at Massachusetts General Hospital to see how Galaxy Watch 8 can help prevent muscle loss in GLP-1 patients.

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Hims & Hers Health ...

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today announced the launch of its at-home Biomarkers Test Kit to Noom members in the United States, making ...